We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Eidogen-Sertanty Announces Collaboration with KAI Pharmaceuticals

News   Oct 19, 2005

 
Eidogen-Sertanty Announces Collaboration with KAI Pharmaceuticals
 
 
 

RELATED ARTICLES

Protein Prods Cancer-fighting T Cells

News

A new protein has been created that mimics the action of a key immune regulatory protein, interleukin 2 (IL-2). IL-2 is a potent anticancer drug and an effective treatment for autoimmune disease, but its toxic side effects have limited its clinical usefulness.

READ MORE

Diversifying Drug Development with New Metal Catalyst

News

A team of researchers has developed a new manganese-based catalyst that can change the structure of drug-like molecules to make new drugs, advancing the pace and efficiency of drug development.

READ MORE

Improved Treatment for Alcohol Use Disorders

News

Helping people with addictions has become a research passion for Purdue University researchers who is leading a team to make drug discoveries to support millions around the world dealing with alcohol use disorders, chronic pain and mood disorders. The team's recent discovery provides a new avenue for the development of medications that provide therapeutic relief for a patient without causing unwanted side effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE